Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Cofactor Joins FNIH Biomarkers Consortium to Add Predictive Immune Modeling Expertise as New Resource for Multidimensional Biomarker Discovery

    Jun 28, 2019, 17:09 PM by Michael Croft
    BELFORD, NJ, US - Jun 28, 2019 - Cofactor Joins FNIH Biomarkers Consortium to Add Predictive Immune Modeling Expertise as New Resource for Multidimensional Biomarker Discovery-Contributing to both the Cancer and Inflammation and Immunity Steering Committees-SAN FRANCISCO--(BUSINESS WIRE)-- Cofactor Genomics, pioneers in the field of Predictive Immune Modeling, announced today that they have become a member of the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium with the goal of advancing the adoption of multidimensional biomarkers in cancer and immune-related diseases
    Full story
  • NEW MONOCLONAL ANTIBODY FOR RUBELLA TESTING AVAILABLE FROM BINDING SITE

    Jun 28, 2019, 14:25 PM by Michael Croft
    SAN DIEGO - Jun 28, 2019 - ~~San Diego, CA . . . . BINDING SITE'sIMMUNOLOGICALS GROUP is pleased to announce the addition of a new, purified monoclonal antibody to be used for the analysis and testing of the Rubella
    Full story
  • The RGC UK Biobank Consortium Data Delivery And Cohort Browser

    Jun 28, 2019, 11:15 AM by Michael Croft

    Bio-IT World | The Regeneron Genetics Center has undertaken the exome sequencing and analysis of 500,000 samples from the UK Biobank, using the DNAnexus Platform to host the dataset and run Regeneron’s software pipeline. To increase the value to the RGC UKB consortium, Regeneron and DNAnexus partnered to construct a combined database of the UKB genomic and phenotypic data to explore through an innovative user interface.

    Full story
  • BOC Sciences Upgrades Its Product Line Specially Targeted for Life Science Research

    Jun 26, 2019, 21:27 PM by Michael Croft
    SHIRLEY, NY, UNITED STATES - Jun 27, 2019 - As a well-established chemical supplier based in New York, BOC Sciences announces to upgrade one of its product lines specially targeted for life science research, including small molecules in stem cell, carbohydrates, nucleosides & nucleotides as well as fluorescent probes
    Full story
  • AbbVie, Discngine Collaborate On Structure-Based Drug Discovery Explorer

    Jun 26, 2019, 09:55 AM by Michael Croft

    Bio-IT World | Although wildly used, rational structure-based drug design techniques are far from being applied to their fullest potential. AbbVie and Discngine addressed the pitfalls by co-developing a web-based structural knowledge management solution called 3decision.

    Full story
  • X4 Pharmaceuticals Initiates Pivotal Phase 3 Clinical Trial of Mavorixafor for the Treatment of WHIM Syndrome

    Jun 26, 2019, 09:02 AM by Michael Croft
    CAMBRIDGE, MA, US - Jun 26, 2019 - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced the initiation of 4WHIM, a pivotal Phase 3 global clinical trial of mavorixafor (X4P-001) for the treatment of WHIM (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis) syndrome, a rare, inherited, primary immunodeficiency disease
    Full story
  • Creative Biolabs Provides Diabody Service to Customers for Research Use

    Jun 26, 2019, 02:46 AM by Michael Croft
    ACCORD, NY - Jun 25, 2019 - June 25, 2019, as one of the most successful suppliers in the field of antibody production, Creative Biolabs developed diabody service to customers for both academic and clinical research use
    Full story
  • Genedata Expands Collaboration with AstraZeneca on Deep Learning for High-Content Image Analysis

    Jun 25, 2019, 13:24 PM by Michael Croft
    BASEL, SWITZERLAND - Jun 25, 2019 - Genedata, a leading provider of advanced software solutions for biopharmaceutical R&D, today announced a collaboration with AstraZeneca to automate high-content screening (HCS) image analysis using Genedata Imagence®
    Full story
  • LabTwin’s AI-powered Digital Assistant Now Talks Back and Connects Data Sources in the Lab with New Open API

    Jun 25, 2019, 10:37 AM by Michael Croft
    BERLIN, N/A, GERMANY - Jun 3, 2019 - LabTwin  GmbH, the world's first voice and AI-powered digital lab assistant, today announced its new open API that will connect scientists with data sources both inside and outside of the lab
    Full story
  • Certara Announces First Recipients of Certara-Monash University Industry Drug Development Fellowships

    Jun 25, 2019, 09:43 AM by Michael Croft
    PRINCETON, NJ - Jun 25, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, and Monash University today announced the recipients of the inaugural Certara-Monash University Industry Drug Development Fellowships – Dr
    Full story
  • Sentieon's 'Faster/Cheaper' Genomics Tools

    Jun 25, 2019, 08:50 AM by Michael Croft

    Bio-IT World | Sentieon's DNAseq and TNseq software, are making waves in the life sciences, creating a "drop in replacement" that is a faster and cheaper alternative to the industry standard for secondary analysis in next-generation sequencing (NGS) data processing while producing the industry standard results.

    Full story
  • Medherant positions itself for the next stage of its development with the appointment of a new CEO

    Jun 25, 2019, 06:13 AM by Michael Croft
    COVENTRY, UK - Jun 25, 2019 - Medherant Limited (“Medherant”), the clinical-stage company developing innovative products for pain and CNS diseases using a unique transdermal delivery technology, TEPI Patch®, has appointed John Burt as Chief Executive Officer, effective 24 June 2019
    Full story
  • Creative Proteomics Has Launched a Wide Range of Newly-developed Proteomics Analysis Services for Biologists

    Jun 25, 2019, 03:12 AM by Michael Croft
    SHIRLEY, NY, US - Jun 25, 2019 - Creative Proteomics, a leading supplier in metabolomics services, has recently released its several newly-developed proteomics services to researchers
    Full story
  • Positive Technologies launches PT Application Inspector Enterprise to create secure web applications

    Jun 24, 2019, 19:58 PM by Michael Croft
    FRANGINGHAM, MA, UNITED STATES - Jun 24, 2019 - Positive Technologies today unveiled PT Application Inspector Enterprise (PT AI Enterprise), a solution that automatically detects vulnerabilities and offers security experts the verification tools they need to secure web applications
    Full story
  • Tracking The Clinical And Preclinical Progress In Targeting Membrane Proteins

    Jun 24, 2019, 11:45 AM by Michael Croft

    Bio-IT World | G protein-coupled receptors (GPCRs), ion channels, and transporters represent some of the most important drug target classes across a wide range of diseases. According to Catherine Hutchings, progress in targeting these membrane proteins requires a recognition of not only what works, but also what doesn't.

    Full story
  • Officials Say They Lack Authority To Halt CRISPR Babies Plan In Russia

    Jun 24, 2019, 11:35 AM by Michael Croft

    STAT | Two influential leaders in science for the first time publicly condemned a Russian biologist who said he plans to produce gene-edited babies but conceded that it was beyond their organizations’ authority to halt him from doing so.

    Full story
  • CD Genomics Announces Highly Sensitive and Accurate Genome Sequencing Services Related to Genome Research

    Jun 24, 2019, 05:59 AM by Michael Croft
    SHIRLEY, NY - Jun 24, 2019 - SHIRLEY, NY, UNITED STATES – Jun 24, 2019 - CD Genomics, the USA-based genetic sequencing company and an expert in transcriptomics and next generation sequencing, announces the technical escalation of sequencing services, The updated service ranges include five: mitochondrial DNA sequencing, microbial whole genome sequencing, plasmid DNA sequencing, SMRT sequencing and bacterial genome sequencing, which are based on some of the most powerful platforms in this field with unrivaled accuracy and sensitivity
    Full story
  • Steven Daniel joins Cofactor Genomics as Vice President of Business Development

    Jun 20, 2019, 15:00 PM by Michael Croft
    SAN FRANCISCO, CA, UNITED STATES - Jun 20, 2019 - Cofactor Genomics today announced the appointment of Steven Daniel, PhD as Vice President of Business Development, overseeing the development and execution of the company’s sales strategy and sales management
    Full story
  • International Women in Engineering Day 2019: Watson-Marlow Fluid Technology Group partners with Goonhilly Earth Station to inspire next generation of female engineers

    Jun 20, 2019, 06:44 AM by Michael Croft
    FALMOUTH, UK - Jun 20, 2019 - One of the South West’s biggest technology companies, Falmouth-based Watson-Marlow Fluid Technology Group (WMFTG) – part of Spirax-Sarco Engineering plc – will celebrate International Women in Engineering Day (INWED) in partnership with Goonhilly Earth Station
    Full story
  • Scilligence and TetraScience Announce Integration Plan to Automate Research Data

    Jun 19, 2019, 20:01 PM by Michael Croft
    CAMBRIDGE, MA, UNITED STATES - Jun 19, 2019 - Scilligence and TetraScience announce a new integration between their products to automate data management across R&D workflows
    Full story
  • «
  • 231
  • 232
  • 233
  • 234
  • 235
  • 236
  • 237
  • 238
  • 239 (current)
  • 240
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy